Inside Washington: User Fee Program Seeks to Spur Biotech Development
Published on:
Jill WechslerBioPharm International, BioPharm International-08-01-2002, Volume 15, Issue 8
PDUFA III boost manufacturer fees to cover postapproval surveillance and streamline the FDA review process